| Prognostic Value of SETD2 Expression in Patients with Metastatic Renal Cell Carcinoma Treated with Tyrosine Kinase Inhibitors | |
| Wang, Jiajun; Liu, Li; Qu, Yang; Xi, Wei; Xia, Yu; Bai, Qi; Xiong, Ying; Long, Qilai; Xu, Jiejie; Guo, Jianming | |
| 刊名 | JOURNAL OF UROLOGY
 |
| 2016 | |
| 卷号 | 196期号:5 |
| 关键词 | carcinoma renal cell neoplasm metastasis survival disease-free survival biomarkers |
| ISSN号 | 0022-5347 |
| URL标识 | 查看原文 |
| 语种 | 英语 |
| 内容类型 | 期刊论文 |
| URI标识 | http://www.corc.org.cn/handle/1471x/4640729 |
| 专题 | 复旦大学上海医学院 |
| 推荐引用方式 GB/T 7714 | Wang, Jiajun,Liu, Li,Qu, Yang,et al. Prognostic Value of SETD2 Expression in Patients with Metastatic Renal Cell Carcinoma Treated with Tyrosine Kinase Inhibitors[J]. JOURNAL OF UROLOGY,2016,196(5). |
| APA | Wang, Jiajun.,Liu, Li.,Qu, Yang.,Xi, Wei.,Xia, Yu.,...&Guo, Jianming.(2016).Prognostic Value of SETD2 Expression in Patients with Metastatic Renal Cell Carcinoma Treated with Tyrosine Kinase Inhibitors.JOURNAL OF UROLOGY,196(5). |
| MLA | Wang, Jiajun,et al."Prognostic Value of SETD2 Expression in Patients with Metastatic Renal Cell Carcinoma Treated with Tyrosine Kinase Inhibitors".JOURNAL OF UROLOGY 196.5(2016). |
| 个性服务 |
| 查看访问统计 |
| 相关权益政策 |
| 暂无数据 |
| 收藏/分享 |
除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。
修改评论